Suile Ointment Wound Dressing HEDONIST BIOCHEMICAL TECHNOLOGIES CO. LTD.

Suile is featured with its fast-healing and no scar. When we use Suile on wounds, it can improve proliferation of both vessels and granulation, and keep the hair follicle in good shape. Moreover, when we use Suile on skin with no wounds, it can not only whiten our skin but reduce inflammation and bioburden. Suile's patent formula contains BSG and BO to help the synthesis of Collagen and Fibroblast, which is essential to surgical wound caring or skin care.Ingrediesnts:Borneol (0.7%): Decreases infl ammation

Bismuth Subgallate (4.5%): Antioxidant Antimicrobial Wound bed preparation: Hemostasis Maintains moist environment Controls bacterial burden

Petroleum Base (94.8%): Barrier against excessive moistureBismuth Subgallate/Borneal (Suile™) is Superior to Bacitracin in the Human Forearm Biopsy Model for Acute Wound HealingBackground The human forearm biopsy model can evaluate the effect of novel agents on acute wounds. Bismuth Subgallate/Borneol (Suile™) is a new product with FDA permission for the treatment of partial thickness wounds.Methods In a randomized, investigator-blinded study, 20 normal healthy volunteers underwent two 6mm full-thickness skin punch biopsies on the flexor surface of each forearm (two wounds/subject). Biopsies were randomly assigned to control (bacitracin) or to test article (Suile™). Wounds were examined, measured by digital planimetry, and photographed daily until healed. Adverse events and pain levels were monitored. Time-tocomplete closure was determined.Results Direct quantitative and qualitative comparisons of wound healing were observed. Although this study was powered to demonstrate equivalence, the Suile™ group trended strongly towards more rapid healing (log-rank analysis). Individual subject arm analysis examined which treatment healed fi rst. Suile™ treated biopsies healed more rapidly (p=0.03, Pearson’s chi-square test).Conclusion Although this study was powered to demonstrate equivalence, there is convincing evidence that Suile™ is superior to Bacitracin in this model. Based on these results, future studies in full thickness wounds with Suile™ are warranted. Also to note, the biopsy model has several advantages: direct comparison within subjects, rapid study completion, good patient compliance, and experience with products prior to embarking on larger clinical trials in wounds.1Advances in Skin & Wound Care. 20(9):485-492, September 2007.Additional Clinical Trial PapersThe Efficacy of Bismuth Subgallate/Borneol (Suile) in the Treatment of Partial Thickness Wounds in the Skilled Nursing SettingBismuth Subgallate/Borneol (Suile™) Results in Less Scarring than A Topical Antimicrobial: Follow up analysis of a randomized clinical trialAround the world, hundreds of millions of patients suffer from chronic non-healing wounds. In the United States, this figure is estimated to be well over 10 million. Most people, at some point in their lifetime, experience acute wounding and there is a clear need to develop agents for the treatment of both chronic and acute wounds. The Testimonials from these patients are a true testament to Suile™.More Testimonials to the power of Suile™:A 92 year old gentleman developed several stage II pressure ulcerations resulting from shear forces. Standard topical treatment resulted in no improvement. Suile™ was then applied daily. The wounds healed completely in seven days.A patient in a skilled nursing facility with partial thickness perineal and buttock skin breakdown not improving with Zinc Oxide. Suile™ applied twice daily. All of the wounds were resolved in seven days.A 71 year old female with skin breakdown of the abdominal wall, secondary to enterocutaneous fi stula. Treatment with Suile™ resulted in rapid improvement in three days.Second Degree Burn Victim. Treatment with Suile™ resulted in dramatic improvement.